SPY320.16+8.80 2.83%
DIA272.25+8.92 3.39%
IXIC9,832.84+217.03 2.26%

Citigroup Initiates Coverage On ORIC Pharmaceuticals with Neutral Rating, Announces Price Target of $35

Citigroup initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Neutral rating and announces Price Target of $35.

Benzinga · 05/19/2020 11:40

Citigroup initiates coverage on ORIC Pharmaceuticals (NASDAQ:ORIC) with a Neutral rating and announces Price Target of $35.